# The BRIGHT Study (Device Name: HALO System)

> **NCT07745998** · NA · NOT_YET_RECRUITING · sponsor: **Indigo Diabetes NV** · enrollment: 12 (estimated)

## Conditions studied

- Diabetes Mellitus - Type 1
- Diabetes Mellitus - Type 2
- Diabetes Mellitus
- Ketoacidosis, Diabetic
- Hyperglycaemia (Diabetic)
- Hypoglycemia (Diabetic)

## Interventions

- **DEVICE:** The HALO System

## Key facts

- **NCT ID:** NCT07745998
- **Lead sponsor:** Indigo Diabetes NV
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745998, "The BRIGHT Study (Device Name: HALO System)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07745998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*